Pharmaceutical

Filter

Current filters:

None

Popular Filters

7001 to 7025 of 7028 results

European action needed to protect patients from unlicensed/off-label medicines, say patient groups

22-09-2011

Four European patient organizations have published a consensus statement raising concerns about the unlicensed…

HealthcareMarkets & MarketingPharmaceuticalRegulation

URMC research shows Lilly’s Forteo could extend life of arthritic joints

22-09-2011

A drug already approved to build bone mass in patients with osteoporosis also builds cartilage around…

Anti-Arthritics/RheumaticsEli LillyForteoPharmaceuticalResearch

Almirall enters integrated discovery agreement with Proteros

22-09-2011

Spain’s largest pharma company Almirall (ALM. MC) and privately-held German firm Proteros biostructures…

AlmirallPharmaceuticalProterosResearch

High demand for monoclonal antibodies will drive therapeutic proteins market

22-09-2011

The global therapeutic proteins market will grow at a moderate pace, with monoclonal antibodies considered…

AmgenBiotechnologyGlobalMarkets & MarketingNovo NordiskPharmaceuticalRoche

Australian Senate Committee rejects ban on gene patents

22-09-2011

Australia’s pharma and biotech industries breathed a sigh of relief, when a Private Members Bill…

Asia-PacificBiotechnologyPatentsPharmaceutical

Newly-formed FKD Therapies gets rights to Merck & Co gene therapy portfolio

22-09-2011

FKD Therapies Oy, a recently-formed company in Finland specializing in advanced gene based medicines,…

FKD TherapiesLicensingMerck & CoOncologyPharmaceutical

Sanofi Pasteur enters $3 billion acne treatment market in deal with UC San Diego

22-09-2011

Moving into a new therapeutic sector, Sanofi Pasteur, the vaccines division of French drug major Sanofi…

LicensingPharmaceuticalResearchSanofiSanofi PasteurVaccines

Call for EU-level action for better adherence to therapies from medical and pharma trade groups

21-09-2011

In a lunch debate held at the European Parliament in Brussels, Belgium, the Standing Committee of European…

EuropeHealthcarePharmaceuticalRegulation

Boehringer once-daily AIDS drug Viramune cleared in EU

21-09-2011

Independent German drug major Boehringer Ingelheim says that once-daily Viramune (nevirapine) prolonged-release…

Anti-viralsBoehringer IngelheimEuropePharmaceuticalRegulationViramune

Macular edema therapeutics market set to reach $2.57 billion by 2018

21-09-2011

The macular edema therapeutics market is forecast to show significant growth until 2018, according to…

GlobalMarkets & MarketingOphthalmicsPharmaceutical

Orexigen and FDA find way forward for obesity drug Contrave

21-09-2011

Shares of US drug developer Orexigen Therapeutics (Nasdaq: OREX) 86% to $2.74 in extended trading yesterday,…

ContraveMetabolicsNorth AmericaOrexigen TherapeuticsPharmaceuticalRegulationResearchTakeda Pharmaceuticals

Bristol-Myers and Pfizer’s blood thinner Eliquis debuts in UK

21-09-2011

US drug majors Bristol-Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) say that their Eliquis (apixaban),…

Bristol-Myers SquibbCardio-vascularEliquisEuropeMarkets & MarketingPfizerPharmaceutical

Pfizer invests $200 million in its Grange Castle, Ireland, facility

20-09-2011

Pfizer (NYSE: PFE), the world’s leading pharmaceutical company, is to make a substantial investment…

BiotechnologyEuropeFinancialPfizerPharmaceutical

Azur Pharma agrees to all-stock merger with Jazz Pharma to create firm with $474 million revenues

20-09-2011

USA-based drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) and privately-held Azur Pharma have agreed to…

Azur PharmaJazz PharmaceuticalsMergers & AcquisitionsPharmaceutical

Russia’s PharmSintez to invest $160 million in construction of new plants

20-09-2011

PharmSintez (LFE: RU), one of Russia’s leading pharmaceutical companies, plans to significantly…

FinancialPharmaceuticalPharmSintez

Soligenix shares decimated as firm puts hold on orBec development

20-09-2011

New Jersey, USA-based Soligenix (OTCBB: SNGX) saw its shares plummet 85% to just $0.03 last week, after…

Gastro-intestinalsLicensingorBecPharmaceuticalResearchSigma-TauSoligenix

Alkermes completes Elan DT buy; signs manufacturing deal

19-09-2011

US drugmaker Alkermes (Nasdaq: ALKS) says it has now completed its previously-announced acquisition of…

AlkermesElanElan Drug TechnologiesMergers & AcquisitionsPharmaceutical

7001 to 7025 of 7028 results

Back to top